Unique ID issued by UMIN | UMIN000039050 |
---|---|
Receipt number | R000044503 |
Scientific Title | Tokyo / Kanagawa / Chiba / Shizuoka / Ibaraki active OCT applications for ACS (TACTICS registry) |
Date of disclosure of the study information | 2020/01/06 |
Last modified on | 2023/01/26 12:03:39 |
Tokyo / Kanagawa / Chiba / Shizuoka / Ibaraki active OCT applications for ACS (TACTICS registry)
TACTICS registry
Tokyo / Kanagawa / Chiba / Shizuoka / Ibaraki active OCT applications for ACS (TACTICS registry)
TACTICS registry
Japan |
Acute Coronary Syndrome (ACS)
Cardiology |
Others
NO
The aim of this study is to evaluate the etiology of acute coronary syndrome in Japan using OCT and investigate its relationship to prognosis.
Others
To investigate the relationship between non-culprit plaque and clinical events.
Exploratory
Explanatory
Phase IV
Evaluation of culprit lesion of ACS using OCT
1. Plaque rupture
2. Plaque erosion
3. Calcified nodule
4. Spontaneous coronary artery dissection
5. Others
6. Undecidable
1.OCT evaluation
2.Angiographic endpoints
3.clinical events
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Inclusion Criteria
1) Patient who perform primary PCI for acute coronary syndrome (unstable angina and acute myocardial infarction)
2) ACS patients who underwent primary PCI using optical coherence tomography.
3) All patients or proxies receive from physicians the information necessary to give informed consent in writing.
4) Patients aged more than 20 years old.
Exclusion Criteria
1) Patient with limited life expectancy<2 years
2) Patients who can not continue DAPT of aspirin and P2Y12 receptor antagonist.
3) Planned surgery within 3 months.
4) Pregnant or possibility of pregnancy.
5) ACS at a lesion where a stent has already been implanted.
6) Patients unsuitable for OCT-guided PCI.
7) Patient with a history of side effects from aspirin, clopidogrel, or prasugrel.
8) Patients who are difficult to receive 12 months follow-up after primary PCI.
9) Patients judged inappropriate for this study.
700
1st name | Toshiro |
Middle name | |
Last name | Shinke |
Showa University
Division of Cardiology
142-8666
1-5-8, Hatanodai Shinagawa-ku, Tokyo
03-3784-8539
shinke@med.showa-u.ac.jp
1st name | Takuya |
Middle name | |
Last name | Mizukami |
TACTICS Study Secretariat
Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics
157-8577
6-11-11, Kitakarasuyama, Setagaya-ku, Tokyo
03-3300-5247
tactics@ofc.showa-u.ac.jp
Showa University Division of Cardiology
Abbott Medical Japan LLC.
Profit organization
japan
Showa University Certified Review Board
1-5-8, Hatanodai Shinagawa-ku, Tokyo
03-3784-8129
m-rinri@ofc.showa-u.ac.jp
NO
昭和大学病院、昭和大学藤が丘病院、昭和大学横浜市北部病院、昭和大学江東豊洲病院、江戸川病院、NTT東日本関東病院、亀田総合病院、関東労災病院、菊名記念病院、榊原記念病院、順天堂大学病院、順天堂大学静岡病院、新東京病院、聖マリアンナ医科大学、帝京大学医学部附属病院、東海大学医学部付属病院、東京医科歯科大学、東京医科大学病院、東京女子医科大学、東京大学医学部附属病院、日本医大千葉北総病院、ひたち医療センター、武蔵野赤十字病院、横浜栄共済病院、横浜市立大学病院付属市民病院医療センター、横浜南共済病院、綾瀬循環器病院、土浦協同病院
2020 | Year | 01 | Month | 06 | Day |
Partially published
702
No longer recruiting
2019 | Year | 11 | Month | 13 | Day |
2019 | Year | 11 | Month | 13 | Day |
2019 | Year | 11 | Month | 13 | Day |
2022 | Year | 03 | Month | 31 | Day |
Follow up on each patients for 24 months after Primary PCI procedure.
2020 | Year | 01 | Month | 04 | Day |
2023 | Year | 01 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044503
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |